Related Experiment Video

Updated: Jun 4, 2026

Application of Dixon's Up-and-Down Design to Estimate the Minimum Alveolar Concentration of Sevoflurane in Rats with Refined Movement Classification
03:02

Application of Dixon's Up-and-Down Design to Estimate the Minimum Alveolar Concentration of Sevoflurane in Rats with Refined Movement Classification

Published on: July 25, 2025

Blockade of 5-HT(2A) and/or 5-HT(2C) receptors modulates sevoflurane-induced immobility

Hirokazu Nagatani1, Tsutomu Oshima, Akiyoshi Urano

  • 1Department of Anesthesiology, Teikyo University Chiba Medical Center, Chiba 299-0111, Japan.

Journal of Anesthesia
|March 2, 2011
PubMed
Abstract

Insights

This study investigated how blocking serotonin receptors affects sevoflurane's ability to prevent movement during painful stimuli in rats. Blocking 5-HT(2A) and 5-HT(2C) receptors lowered the minimum alveolar concentration (MAC) needed for immobility.

Area of Science:

  • Anesthesiology
  • Neuropharmacology
  • Serotonin receptor research

Background:

  • 5-hydroxytryptamine (5-HT)(2A) receptors are known to influence the anesthetic effects of isoflurane.
  • The role of these receptors in sevoflurane's immobility-inducing properties remains uncharacterized.
  • Understanding receptor modulation is crucial for optimizing anesthetic protocols.

Purpose of the Study:

  • To investigate the impact of 5-HT(2A) and 5-HT(2C/2B) receptor blockade on sevoflurane's minimum alveolar concentration (MAC) in rats.
  • To determine if specific serotonin receptor antagonists can modulate sevoflurane-induced immobility.
  • To explore the neural circuitry underlying sevoflurane's anesthetic action.

Main Methods:

  • Male Wistar rats were pretreated with intraperitoneal injections of altanserin (5-HT(2A) antagonist) or SB 206553 (5-HT(2C/2B) antagonist) 30 minutes before MAC testing.
  • A vehicle control group received no drug pretreatment.
  • MAC was determined by assessing the minimum sevoflurane concentration required to prevent movement in response to tail clamping.

Main Results:

  • The rank order of MAC values, from lowest to highest, was: altanserin < SB 206553 < vehicle control.
  • Pretreatment with altanserin resulted in the lowest MAC values, indicating enhanced immobility.
  • SB 206553 also reduced MAC compared to the control group.

Conclusions:

  • The findings suggest that 5-HT(2A) and 5-HT(2C) receptors play a role in the neural pathways that influence sevoflurane MAC.
  • Blockade of these serotonin receptors can modulate the immobility induced by sevoflurane during noxious stimulation.
  • This implies potential for targeted pharmacological interventions to adjust sevoflurane's anesthetic efficacy.

More Related Videos

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

Related Concept Videos

Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions01:27

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action01:17

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...